Home  >  Products  >  Lhfpl3 (lipoma HMGIC fusion partner-like 3 ) Blocking Peptide (the C terminal of Lhfpl3)(100ug)
Lhfpl3 (lipoma HMGIC fusion partner-like 3 ) Blocking Peptide (the C terminal of Lhfpl3)(100ug)

Lhfpl3 (lipoma HMGIC fusion partner-like 3 ) Blocking Peptide (the C terminal of Lhfpl3)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-Lhfpl3 Antibody (ARP66844_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human, Mouse
Presku: AAP66844
Size: 100ug
Weight: 25kDa
Gene: 269629
Format: Lyophilized powder
Target: The function of this protein remains unknown.
Alternative names: A930031L14Rik
See Full Product Listings >